InsiderSignalSign in

← Insider buys

RVNC

Revance Therapeutics, Inc.

No insider bought or sold Revance Therapeutics, Inc. in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

RVNC over the last year

Prices for RVNC aren't in yet.

RVNC after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

63 insider filings since 2016, newest first

Lauren P Silvernail · CFO, CBO, Secretary

$268K−17.0%Nov 9

L Daniel Browne · CEO and President

$200K−5.0%Oct 20

Lauren P Silvernail · CFO, CBO, Secretary

$298K−19.0%Oct 16

L Daniel Browne · CEO and President

$179K−5.0%Sep 22

L Daniel Browne · CEO and President

$519K−13.0%Aug 25

Lauren P Silvernail · CFO, CBO, Secretary

$36K−5.0%May 24

L Daniel Browne · CEO and President

$649K−16.0%May 24

L Daniel Browne · CEO and President

$227K−5.0%Feb 24

L Daniel Browne · CEO and President

$237K−6.0%Jan 27

L Daniel Browne · CEO and President

$251K−6.0%Dec 30

L Daniel Browne · CEO and President

$215K−5.0%Nov 25

L Daniel Browne · CEO and President

$178K−5.0%Oct 28

Curtis Ruegg · EVP, Technical Operations

$66K−10.0%Jan 8

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.